Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05615948
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:05.458269+00:00
Published At
2026-04-21T00:00:00+00:00
Record Updated At
2026-04-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Treatment Resistant Depression", "Major Depressive Disorder", "Analgesia", "Ketamine", "Peripheral Nervous System Agents", "Central Nervous System Depressants", "Neurotransmitter Agents", "Anti-Inflammatory Agents", "Physiological Effects of Drugs", "Sensory System Agents", "Analgesics, Non-Narcotic", "Anti-Inflammatory Agents, Non-Steroidal", "Depressive Symptoms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-21"
protocolSection.identificationModule.nctId
"NCT05615948"
protocolSection.identificationModule.officialTitle
"An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Treatment Resistant Depression (protocolSection.conditionsModule.conditions)
  • Major Depressive Disorder (protocolSection.conditionsModule.conditions)
  • Analgesia (protocolSection.conditionsModule.conditions)
  • Ketamine (protocolSection.conditionsModule.conditions)
  • Peripheral Nervous System Agents (protocolSection.conditionsModule.conditions)
  • Central Nervous System Depressants (protocolSection.conditionsModule.conditions)
  • Neurotransmitter Agents (protocolSection.conditionsModule.conditions)
  • Anti-Inflammatory Agents (protocolSection.conditionsModule.conditions)
  • Physiological Effects of Drugs (protocolSection.conditionsModule.conditions)
  • Sensory System Agents (protocolSection.conditionsModule.conditions)
  • Analgesics, Non-Narcotic (protocolSection.conditionsModule.conditions)
  • Anti-Inflammatory Agents, Non-Steroidal (protocolSection.conditionsModule.conditions)
  • Depressive Symptoms (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.